Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the effects of different doses of methotrexate (MTX) when taken with adalimumab in subjects with early rheumatoid arthritis (RA).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01185301
Study type Interventional
Source AbbVie
Contact
Status Completed
Phase Phase 3
Start date October 2010
Completion date September 2012

See also
  Status Clinical Trial Phase
Completed NCT01762176 - Early RA MRI Early Intensive Treatment Study N/A
Completed NCT01768923 - Early RA Vascular Randomised Controlled Study N/A
Recruiting NCT03755258 - Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis Phase 1
Recruiting NCT03389711 - INCMNSZ - Rheumatoid Arthritis Cohort
Completed NCT00195663 - Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis Phase 3
Completed NCT04752748 - Power Doppler in Hand Joints of Early RA Patients